高磊，1977年生，籍貫山東聊城，流行病學(xué)專業(yè)，病原生物學(xué)研究所研究員，博士生導(dǎo)師。1994年考入山東農(nóng)業(yè)大學(xué)獸醫(yī)學(xué)專業(yè)，1998年獲得學(xué)士學(xué)位。1998年于中國(guó)農(nóng)業(yè)科學(xué)院預(yù)防獸醫(yī)學(xué)專業(yè)攻讀碩士學(xué)位。2006年于德國(guó)海德堡大學(xué)流行病學(xué)專業(yè)攻讀博士學(xué)位，從事感染相關(guān)腫瘤的流行病學(xué)研究。2009年留學(xué)歸國(guó)全職進(jìn)入中國(guó)醫(yī)學(xué)科學(xué)院病原生物學(xué)研究所工作至今，從事傳染病流行病學(xué)研究。2010年獲聘副研究員，2016年獲聘研究員。

主要從事結(jié)核潛伏感染的流行病學(xué)調(diào)查和預(yù)防干預(yù)研究，通過(guò)開(kāi)展大規(guī)模、多中心的隊(duì)列研究和隨機(jī)對(duì)照臨床試驗(yàn)探索適宜我國(guó)國(guó)情和人群特征的結(jié)核潛伏感染預(yù)防干預(yù)新技術(shù)、新方案和新策略。

午夜92福利1000,午夜92福利1000,久久国产亚洲高清观看5388,美女不拍网站免费观看,欧美***天天久久综合精品,中文字幕日韩系列中文字幕,综合久久国产九一剧情麻豆,丰满人妻在线免费视频,奶子大逼又嫩操起来真爽

1. Xin H#, Cao X#, Zhang H#, Feng B, Du Y, Zhang B, Wang D, Liu Z, Guan L, Shen F, Guan X, Yan J, He Y, He Y, Quan Z, Pan S, Liu J, Jin Q, Gao L*. Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial. Eur Respir J. 2022;60(1):2102359. (IF=33.795)

2. Xin H#, Cao X#, Zhang H#, Liu J#, Pan S#, Li X, Guan L, Shen F, Liu Z, Wang D, Guan X, Yan J, Li H, Feng B, Zhang M, Yang Q, Jin Q, Gao L*; LATENTTB-NSTM study team. Dynamic changes of interferon-gamma Release Assay results along with latent tuberculosis infection treatment. Clin Microbiol Infect. 2020;26(11):p1555.e1-7. (IF=8.067)

3. Xin H#, Zhang H#, Yang S#, Liu J#, Lu W#, Bai L#, Cao X, Feng B, Jin Q, Gao L*. 5-year follow-up of active tuberculosis development from latent infection in rural China. Clin Infect Dis. 2020;70(5):947-50. (IF=9.079)

4. Xin H#, Zhang H#, Liu J#, Pan S#, Li X, Cao X, Feng B, Guan L, Shen F, Liu Z, Wang D, Yan J, Zhang M, Yang Q, Jin Q, Gao L*. Mycobacterium Tuberculosis Infection Among the Elderly in 20 486 Rural Residents Aged 50-70 Years in Zhongmu County, China. Clin Microbiol Infect. 2019;25(9):1120-6. (IF=7.117)

5. Xin H#, Zhang H, Cao X, Li X, Li M, Feng B, Jin Q, Gao L*. Serum level of IL-8 is associated with reversion of QuantiFERON-TB gold in-tube tests. J Infect. 2019;78(4):292-8. (IF=4.842)

6. Zhang H#, Xin H#, Wang D#, Pan S, Liu Z, Cao X, Wang J, Li X, Feng B, Li M, Yang Q, Zhang M, Jin Q, Gao L*. Serial Testing of Mycobacterium Tuberculosis Infection in Chinese Village Doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube and T-SPOT.TB. J Infect. 2019;78(4):305-10. (IF=4.842)

7. Gao L#*, Zhang H#, Xin H#, Liu J#, Pan S#, Li X, Guan L, Shen F, Liu Z, Wang D, Guan X, Yan J, Li H, Feng B, Cao X, Chen Y, Cui W, Zhang Z, Ma Y, Chen X, Zhou X, Jin Q*; LATENTTB-NSTM study team. Short-course Regimens of Rifapentine plus Isoniazid to Treat Latent Tuberculosis Infection in Older Chinese: a Randomised Controlled Study. Eur Respir J. 2018;52 (6):1801470. (IF=11.807)

8. Gao L#, Li X#, Liu J#, Wang X#, Lu W#, Bai L#, Xin H, Zhang H, Li H, Zhang Z, Ma Y, Li M, Feng B, Du J, Sui H, Zhao R, Su H, Pan S, Guan L, Shen F, He J, Yang S, Si H, Cheng X, Xu Z, Tan Y, Chen T, Xu W, Peng H, Wang Z, Zhu T, Chen X, Zhou X, Guan X, Jin Q*; LATENTTB-NSTM study team. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicenter, prospective cohort study. Lancet Infect Dis. 2017;17(10):1053-61. (IF=25.148, R)

9. Gao L#*, Bai L#, Liu J#, Lu W#, Wang X#, Li X, Du J, Chen X, Zhang H, Xin H, Sui H, Li H, Su H, He J, Pan S, Peng H, Xu Z, Catanzaro A, Evans TG, Zhang Z, Ma Y, Li M, Feng B, Li Z, Guan L, Shen F, Wang Z, Zhu T, Yang S, Si H, Wang Y, Tan Y, Chen T, Chen C, Xia Y, Cheng S, Xu W, Jin Q*; LATENTTB-NSTM study team. Annual risk of tuberculosis infection in rural China: a population-based prospective study. Eur Respir J. 2016;48(1):168-78. (IF=10.569)

10. Gao L#, Lu W#, Bai L#, Wang X#, Xu J#, Catanzaro A, Cárdenas V, Li X, Yang Y, Du J, Sui H, Xia Y, Li M, Feng B, Li Z, Xin H, Zhao R, Liu J, Pan S, Shen F, He J, Yang S, Si H, Wang Y, Xu Z, Tan Y, Chen T, Xu W, Peng H, Wang Z, Zhu T, Zhou F, Liu H, Zhao Y, Cheng S, Jin Q*; LATENTTB-NSTM study team. Latent tuberculosis infection in rural China: baseline results of a population-based, multicenter, prospective cohort study. Lancet Infect Dis. 2015;15(3):310-9. (IF=21.372, C100)